CTRI/2022/06/043320
Recruiting
未知
A study to determine the outcome of patients with dysnatremia undergoing slow low efficiency dialysis (SLED) in IC
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: N179- Acute kidney failure, unspecified
- Sponsor
- King George Medical University
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients with age \> 18 years with acute kidney injury (AKI) stage 2 and 3 as defined by KDIGO or Acute on Chronic Kidney disease for whom SLED was prescribed by the treating physician
- •2\. Serum Na less than 135 mmol/L OR more than 145 mmol/L will be screened to be included in the study.
- •3\. Patients with dysnatremia who undergo one session of SLED will be included only once in the study
Exclusion Criteria
- •1\.The patients whose pre dialysis Na is between 135\-145 mmol/L
- •2\.The patients who could not complete the SLED session scheduled for 8\-10 hours
- •3\.Patients who were end stage renal disease and received dialysis before enrolment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Patient-Reported Outcomes Study in Patients with Primary Immunodeficiency in Japan: A Non-interventional Prospective Observational StudyJPRN-UMIN000045622Takeda Pharmaceutical Company Limited.127
Active, not recruiting
Phase 3
Study to evaluate the effect of fluticasone furoate/vilanterol on survivalin subjects with chronic obstructive pulmonary disease who have history of cardiovascular disease.CTRI/2012/04/002563GlaxoSmithKline16,000
Active, not recruiting
Not Applicable
Study to evaluate the effect of fluticasone furoate/vilanterol on survival in subjects with chronic obstructive pulmonary disease.EUCTR2010-021638-72-ITGLAXO SMITH KLINE RESEARCH & DEVELOPMENT LTD16,000
Completed
Not Applicable
A prospective observational study of patients with advanced cancer for the evaluation of checkpoint inhibitor-associated cardiovascular immune-related adverse eventsAdvanced non-small-cell lung cancer and advanced gastric cancer which are indications for anti-cytotoxic T-lymphocyte-associated antigen-4, anti-programmed death-1, and anti-programmed death-ligand 1 antibodies.JPRN-UMIN000032729Frontline Immunotherapy Team, Sendai Kousei Hospital129
Recruiting
Not Applicable
A prospective observational study of patients with ankle sprain and instability in Korean Medicine clinics and hospitalKCT0004016Gachon University200